Valérie CHAUDRU

VALÉRIE CHAUDRU

Maître de Conférences à l'université d'Evry Val d'Essonne, département de biologie  

  • Co-responsable de la L1 science de la vie-chimie
  • Référente de la certification PIX pour l'université d'Evry

En savoir plus

    My research is focused on the search for new genetic factors involved in Rheumatoid Arthritis (RA). RA is a multifactorial disease resulting from genetic and environmental factors with possible Gene-Gene (GxG) and Gene-Environment (GxE) interactions. To date, some genetic factors have been identified including a major one (HLA-DRB1) and others with modest effects. However, these genes do not explain the entire heritability of RA. The aim of my project is to explore some causes of “missing heritability” from sequence data (see sequence variants project).

    Ma recherche est principalement orientée vers l’identification de nouveaux facteurs génétiques dans la Polyarthrite Rhumatoïde (PR). La PR est une maladie multifactorielle résultant de facteurs génétiques et de facteurs environnementaux, avec de possibles interactions Gène-Gène (GxG) et Gène-Environnement (GxE). A ce jour, un certain nombre de facteurs génétiques ont été identifiés et incluent un gène majeur (HLA-DRB1) et une centaine d’autres facteurs génétiques à effets modérés. Cependant, ces facteurs génétiques n’expliquent pas la totalité de la composante génétique de la PR. L’objectif de mon projet est d’explorer différentes causes de l’héritabilité manquante à partir de données de séquence (pour plus de détails voir projet sequence variants).

    Research domain

    • Genetic Epidemiology (linkage & association analyses) for complex diseases
    • Sequencing data analyses (DNA-seq) for complex diseases
    • Depuis 2018 : Quentin Miagoux, doctorant (co-encadrement avec  Elisabeth Petit-Teixeira, 50% et Anna Niaraki, 25% )
    • 2019 : Fairouz Hammal, Stage M2 GENIOME
    • 2015-2018 : Maëva Veyssiere, doctorante (co-encadrement avec  Javier Perea, 50%)
    • 2018 : Melissa Saichi, stage M1 Bio-informatique, université Paris Diderot, (co-encadrement avec Maëva Veyssiere,50%) : Construction d'une carte de CNVs du génome humain et calcul de fréquence d'évènements. 
    • 2017 : Zaahith Abdoulatif, stage M1 Biologie-santé, Upsay: Recherche d'interactions gène-gène à partir de données de séquences de gènes candidats dans des familles à cas multiples de polyarthrite rhumatoïde.  
    • Fang J, Jia J, Makowski M, Xu M, Wang Z, Zhang T, Hoskins JW, Choi J, Han Y, Zhang M, Thomas J, Kovacs M, Collins I, Dzyadyk M, Thompson A, O’Neill M, Das S, Lan Q, Koster R, PanScan Consortium, TRICL Consortium, GenoMEL Consortium, Stolzenberg-Solomon RS, Kraft P, Wolpin BM, Jansen PWTC, Olson S, McGlynn KA, Kanetsky PA, Chatterjee N, Barrett JH, Dunning AM, Taylor JC, Newton-Bishop JA, Bishop DT, Andresson T, Petersen GM, Amos CI, Iles MM, Nathanson KL, Landi MT, Vermeulen M, Brown KM, Amundadottir LT. (2017) Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nat Commun; 8:15034.
    • Ben Kilani MS, Achour Y, Perea J, Cornelis F, Bardin T, Chaudru V, Maalej A, Petit-Teixeira E. (2016) Characterization of copy number variants for CCL3L1 gene in rheumatoid arthritis for French trio families and Tunisian cases and controls. Clin Rheumatol; 35(8):1917–1922.
    • Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M, Bille K, Dessen P, d’Hayer B, Mohamdi H, Remenieras A, Maubec E, de la Fouchardière A, Molinié V, Vabres P, Dalle S, Poulalhon N, Martin-Denavit T, Thomas L, Andry-Benzaquen P, Dupin N, Boitier F, Rossi A, Perrot J-L, Labeille B, Robert C, Escudier B, Caron O, Brugières L, Saule S, Gardie B, Gad S, Richard S, Couturier J, Teh BT, Ghiorzo P, Pastorino L, Puig S, Badenas C, Olsson H, Ingvar C, Rouleau E, Lidereau R, Bahadoran P, Vielh P, Corda E, Blanché H, Zelenika D, Galan P, French Familial Melanoma Study Group, Chaudru V, Lenoir GM, Lathrop M, Davidson I, Avril M-F, Demenais F, Ballotti R, Bressac-de Paillerets B. (2016) Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature; 531(7592):126.
    • Fodil M, Teixeira VH, Chaudru V, Hilliquin P, Bombardieri S, Balsa A, Westhovens R, Barrera P, Alves H, Migliorin P, Bardin T, Cornelis F, Boudjema A, Petit-Teixeira E. (2015) Relationship between SNPs and expression level for candidate genes in rheumatoid arthritis. Scand J Rheumatol; 44(1):2–7.
    • Liang X, Pfeiffer RM, Li W-Q, Brossard M, Burke LS, Wheeler W, Calista D, Fargnoli MC, Ghiorzo P, Peris K, Bianchi-Scarra G, Chaudru V, Zelenika D, Maeder D, Burdette L, Yeager M, Chanock S, Landi MT, Demenais F, Tucker MA, Goldstein AM, Yang XR. (2014) Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families. J Invest Dermatol; 134(2):481–487.
    • Iles MM, Law MH, Stacey SN, Han J, Fang S, Pfeiffer R, Harland M, Macgregor S, Taylor JC, Aben KK, Akslen LA, Avril M-F, Azizi E, Bakker B, Benediktsdottir KR, Bergman W, Scarrà GB, Brown KM, Calista D, Chaudru V, Fargnoli MC, Cust AE, Demenais F, de Waal AC, Dębniak T, Elder DE, Friedman E, Galan P, Ghiorzo P, Gillanders EM, Goldstein AM, Gruis NA, Hansson J, Helsing P, Hočevar M, Höiom V, Hopper JL, Ingvar C, Janssen M, Jenkins MA, Kanetsky PA, Kiemeney LA, Lang J, Lathrop GM, Leachman S, Lee JE, Lubiński J, Mackie RM, Mann GJ, Martin NG, Mayordomo JI, Molven A, Mulder S, Nagore E, Novaković S, Okamoto I, Olafsson JH, Olsson H, Pehamberger H, Peris K, Grasa MP, Planelles D, Puig S, Puig-Butille JA, Randerson-Moor J, Requena C, Rivoltini L, Rodolfo M, Santinami M, Sigurgeirsson B, Snowden H, Song F, Sulem P, Thorisdottir K, Tuominen R, Van Belle P, van der Stoep N, van Rossum MM, Wei Q, Wendt J, Zelenika D, Zhang M, Landi MT, Thorleifsson G, Bishop DT, Amos CI, Hayward NK, Stefansson K, Bishop JAN, Barrett JH, GenoMEL Consortium, Q-MEGA and AMFS Investigators. (2013) A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet; 45(4):428–432, 432e1.
    • Maubec E, Chaudru V, Mohamdi H, Blondel C, Margaritte-Jeannin P, Forget S, Corda E, Boitier F, Dalle S, Vabres P, Perrot J-L, Lyonnet DS, Zattara H, Mansard S, Grange F, Leccia M-T, Vincent-Fetita L, Martin L, Crickx B, Joly P, Thomas L, French Familial Melanoma Study Group, Bressac-de Paillerets B, Avril M-F, Demenais F. (2012) Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family. J Am Acad Dermatol; 67(6):1257–1264.
    • Amos CI, Wang L-E, Lee JE, Gershenwald JE, Chen WV, Fang S, Kosoy R, Zhang M, Qureshi AA, Vattathil S, Schacherer CW, Gardner JM, Wang Y, Bishop DT, Barrett JH, GenoMEL Investigators, MacGregor S, Hayward NK, Martin NG, Duffy DL, Q-Mega Investigators, Mann GJ, Cust A, Hopper J, AMFS Investigators, Brown KM, Grimm EA, Xu Y, Han Y, Jing K, McHugh C, Laurie CC, Doheny KF, Pugh EW, Seldin MF, Han J, Wei Q. (2011) Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet; 20(24):5012–5023.
    • Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M, Bille K, Dessen P, d’Hayer B, Mohamdi H, Remenieras A, Maubec E, de la Fouchardière A, Molinié V, Vabres P, Dalle S, Poulalhon N, Martin-Denavit T, Thomas L, Andry-Benzaquen P, Dupin N, Boitier F, Rossi A, Perrot J-L, Labeille B, Robert C, Escudier B, Caron O, Brugières L, Saule S, Gardie B, Gad S, Richard S, Couturier J, Teh BT, Ghiorzo P, Pastorino L, Puig S, Badenas C, Olsson H, Ingvar C, Rouleau E, Lidereau R, Bahadoran P, Vielh P, Corda E, Blanché H, Zelenika D, Galan P, French Familial Melanoma Study Group, Aubin F, Bachollet B, Becuwe C, Berthet P, Bignon YJ, Bonadona V, Bonafe J-L, Bonnet-Dupeyron M-N, Cambazard F, Chevrant-Breton J, Coupier I, Dalac S, Demange L, d’Incan M, Dugast C, Faivre L, Vincent-Fétita L, Gauthier-Villars M, Gilbert B, Grange F, Grob J-J, Humbert P, Janin N, Joly P, Kerob D, Lasset C, Leroux D, Levang J, Limacher J-M, Livideanu C, Longy M, Lortholary A, Stoppa-Lyonnet D, Mansard S, Mansuy L, Marrou K, Matéus C, Maugard C, Meyer N, Nogues C, Souteyrand P, Venat-Bouvet L, Zattara H, Chaudru V, Lenoir GM, Lathrop M, Davidson I, Avril M-F, Demenais F, Ballotti R, Bressac-de Paillerets B. (2011) A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature; 480(7375):94–98.
    • Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, Akslen LA, Armstrong BK, Avril M-F, Azizi E, Bakker B, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Corda E, Cust AE, Dębniak T, Duffy D, Dunning AM, Easton DF, Friedman E, Galan P, Ghiorzo P, Giles GG, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Janssen B, Jenkins MA, Jönsson G, Kefford RF, Landi G, Landi MT, Lang J, Lubiński J, Mackie R, Malvehy J, Martin NG, Molven A, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Pastorino L, Puig S, Puig-Butille JA, Randerson-Moor J, Snowden H, Tuominen R, Van Belle P, van der Stoep N, Whiteman DC, Zelenika D, Han J, Fang S, Lee JE, Wei Q, Lathrop GM, Gillanders EM, Brown KM, Goldstein AM, Kanetsky PA, Mann GJ, Macgregor S, Elder DE, Amos CI, Hayward NK, Gruis NA, Demenais F, Bishop JAN, Bishop DT, GenoMEL Consortium. (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet; 43(11):1108–1113.
    • Schoof N, Iles MM, Bishop DT, Newton-Bishop JA, Barrett JH, Genomel Consortium. (2011) Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. PLoS ONE; 6(12):e29451.
    • Maubec E, Chaudru V, Mohamdi H, Grange F, Patard J-J, Dalle S, Crickx B, Paillerets BB, Demenais F, Avril M-F. (2010) Characteristics of the coexistence of melanoma and renal cell carcinoma. Cancer; 116(24):5716–5724.
    • Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N, Melanoma Genetics Consortium. (2010) Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst; 102(20):1568–1583.
    • Galore-Haskel G, Azizi E, Mohamdi H, Scope A, Chaudru V, Laitman Y, Barak F, Pavlotsky F, Demenais F, Friedman E. (2009) MC1R variant alleles and malignant melanoma risk in Israel. Eur J Cancer; 45(11):2015–2022.
    • Chaudru V, Lo MT, Lesueur F, Marian C, Mohamdi H, Laud K, Barrois M, Chompret A, Avril MF, Demenais F, Bressac-de Paillerets B. (2009) Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes. Fam Cancer; 8(4):371–377.
    • Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril M-F, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, de-Paillerets BB. (2007) Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer; 121(4):825–831.
    • Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LAC,Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Lund Melanoma Study Group, Melanoma Genetics Consortium (GenoMEL). (2007) Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet; 44(2):99–106.
    • Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B, French Hereditary Melanoma Study Group. (2006) Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet; 43(1):39–47.
    • Chaudru V, Laud K, Avril M-F, Minière A, Chompret A, Bressac-de Paillerets B, Demenais F. (2005) Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev; 14(10):2384–2390.
    • Bouzigon E, Chaudru V, Carpentier A-S, Dizier M-H, Oryszczyn M-P, Maccario J, Kauffmann F, Demenais F. (2004) Familial correlations and inter-relationships of four asthma-associated quantitative phenotypes in 320 French EGEA families ascertained through asthmatic probands. Eur J Hum Genet; 12(11):955–963.
    • Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril M-F, Demenais F. (2004) Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst; 96(10):785–795.
    • Chaudru V, Laing A, Dunston GM, Adams-Campbell LL, Williams R, Lynch JJ, Leffall LD, DeWitty RL, Gause BL, Bonney GE, Demenais F. (2002) Interactions between genetic and reproductive factors in breast cancer risk in a population-based sample of African-American families. Genet Epidemiol; 22(4):285–297.
    • Demenais F, Chaudru V, Martinez M. (2001) Detection of parent-of-origin effects for atopy by model-free and model-based linkage analyses. Genet Epidemiol; 21 Suppl 

    Email : valerie.chaudruping@univ-evrypong.fr

    phone : 0160874570 

    Retour à la liste des services